Neuland Laboratories P/B Ratio
Neuland Laboratories P/B ratio. Neuland Laboratories (NEULANDLAB) P/B ratio is 13.49 (High), book value per share ₹1442.31 vs Healthcare average P/B of -0.01 — Very High - Significant premium, high growth expectations or speculative. Analyse NEULANDLAB institutional holdings to track promoter, FII and institutional holdings.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
NEULANDLAB P/B Ratio — Valuation Insights & Book Value Analysis
Neuland Laboratories price-to-book ratio interpretation, valuation status and historical context — current P/B 13.49 (High). View NEULANDLAB 52-week high low for the annual high/low range and current price position.
- Stock appears overvalued with PB of 13.49, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 36.3% above historical average
- Trading at premium to sector average PB of -0.01
Neuland Laboratories P/B Ratio Historical Trend
NEULANDLAB annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see Neuland Laboratories screener.
NEULANDLAB Historical P/B Ratio — Book Value Per Share & Year-End Price
Neuland Laboratories annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 13.13 | ₹1442.31 | ₹18935.00 | ₹1,875 | High |
| 2025 | 12.94 | ₹1173.08 | ₹15175.00 | ₹1,525 | High |
| 2024 | 13.91 | ₹986.92 | ₹13723.80 | ₹1,283 | High |
| 2023 | 6.92 | ₹764.62 | ₹5291.40 | ₹994 | High |
| 2022 | 2.58 | ₹646.92 | ₹1666.95 | ₹841 | Moderate |
NEULANDLAB vs Healthcare Peers — P/B Ratio Comparison
Neuland Laboratories P/B 13.49 vs Healthcare average -0.01, median 0.6 — range -6.55–1.06.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.32 | ₹43 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.79 | ₹130 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.22 | ₹53 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |